JAZZ PHARMACEUTICALS FRANCE
- Country
- ๐ซ๐ทFrance
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
Trial of Xyremยฎ (Sodium Oxybate) for the Treatment of Narcolepsy
- Conditions
- Narcolepsy
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 59
- Registration Number
- NCT00132873
- Locations
- ๐จ๐ฆ
Brain and Sleep Diagnostic Centre, Toronto, Ontario, Canada
A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
- Conditions
- Anxiety Disorder
- First Posted Date
- 2005-04-01
- Last Posted Date
- 2008-01-09
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 158
- Registration Number
- NCT00106860
- Locations
- ๐บ๐ธ
Midwest Clinical Research Center, Dayton, Ohio, United States
๐บ๐ธIPS Research Company, Oklahoma City, Oklahoma, United States
๐บ๐ธOregon Center for Clinical Research, Inc., Eugene, Oregon, United States
Experimental Medication For the Treatment of Generalized Anxiety Disorder
- Conditions
- Anxiety Disorder
- First Posted Date
- 2004-11-30
- Last Posted Date
- 2014-10-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 511
- Registration Number
- NCT00097708
- Locations
- ๐บ๐ธ
Princeton Medical Institute, Princeton, New Jersey, United States
๐บ๐ธPharmasite Research, Inc., Baltimore, Maryland, United States
๐บ๐ธSouthwestern Research Institute, Burbank, California, United States
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
- Conditions
- Fibromyalgia
- Interventions
- Drug: Placebo
- First Posted Date
- 2004-07-14
- Last Posted Date
- 2012-01-24
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 195
- Registration Number
- NCT00087555
- Locations
- ๐บ๐ธ
Wallace Rheumatic Study Center, Los Angeles, California, United States
๐บ๐ธRadiant Research, Inc., West Palm Beach, Florida, United States
๐บ๐ธC.A.R.E. Center, Raleigh, North Carolina, United States
Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
- Conditions
- Obstructive Sleep Apnea Syndrome
- Interventions
- First Posted Date
- 2004-07-01
- Last Posted Date
- 2012-02-24
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT00086281
- Locations
- ๐จ๐ฆ
London Health Sciences Centre, Victoria Campus, London, Ontario, Canada
๐บ๐ธClinical Research Group of St. Petersburg, St. Petersburg, Florida, United States
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
- Conditions
- Narcolepsy
- Interventions
- First Posted Date
- 2003-08-06
- Last Posted Date
- 2011-12-29
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 231
- Registration Number
- NCT00066170
- Locations
- ๐บ๐ธ
The Center for Sleep and Wake Disorders/Midwest Neurology, Danville, Indiana, United States
๐บ๐ธClinical Research Group of St. Petersburg, Inc., St. Petersburg, Florida, United States
๐ฉ๐ชPsychiatrische Universitatsklinik, Regensburg, Germany